Gam-COVID-Vac
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, romanized: Gam-KOVID-Vak), trade-named Sputnik V, is a COVID-19 vaccine created by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health.[1][2][3]
Gam-COVID-Vac has been approved for distribution in Russia.[1][4][5]
Gam-COVID-Vac Media
Pharmaceutical company União Quimica started production of Sputnik V in Brazil in January 2021[source?]
Sputnik V, efficacy for different conditions. The error bars indicate the confidence interval containing the efficacy with 95% probability
President Putin's meeting with government members, on 11 August 2020 via videoconference, at which he announced a conditionally registered vaccine against COVID-19.
Medical worker in Moscow with the vaccine
Vaccination of military personnel and civilian specialists of the Northern Fleet with the second component of the drug "Gam-COVID-Vac" ("Sputnik V")
References
- ↑ 1.0 1.1 Callaway E (August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature. 584 (7821): 334–335. doi:10.1038/d41586-020-02386-2. PMID 32782400.
This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population.
- ↑ "Russia's approval of a COVID-19 vaccine is less than meets the press release". Science. 11 August 2020. https://www.sciencemag.org/news/2020/08/russia-s-approval-covid-19-vaccine-less-meets-press-release. Retrieved 13 August 2020.
- ↑ "Scientists ask: Without trial data, how can we trust Russia's COVID vaccine?" (in en). Reuters. 11 August 2020. https://www.reuters.com/article/us-health-coronavirus-vaccine-russia-exp/scientists-ask-without-trial-data-how-can-we-trust-russias-covid-vaccine-idUSKCN2571TL. Retrieved 11 August 2020.
- ↑ Mahase E (August 2020). "Covid-19: Russia approves vaccine without large scale testing or published results". BMJ. 370: m3205. doi:10.1136/bmj.m3205. PMID 32816758.
- ↑ Bar-Zeev N, Inglesby T (September 2020). "COVID-19 vaccines: early success and remaining challenges". Lancet. 396 (10255): 868–869. doi:10.1016/S0140-6736(20)31867-5. PMC 7471800. PMID 32896290.